1-3 of 3
Aurelie Schwarzbach
Close
Sort by
Journal Articles

Omidubicel-Onlv for Allogeneic Transplantation (allo-HCT) in Patients with Hematologic Malignancies: Results of a Multicenter Open Label Expanded Access Program

Mitchell Horwitz, Stephanie B. Tsai, Andrew R. Rezvani, Richard T Maziarz, Uri Goshen, Stuart Levy, Aurelie Schwarzbach, Roei D. Mazor, Patrick J. Stiff, Gary J. Schiller
Journal: Blood
Blood (2023) 142 (Supplement 1): 6894.
https://doi.org/10.1182/blood-2023-181167
Published: 2023
Journal Articles

Allogeneic Stem Cell Transplantation with Omidubicel: Long-Term Follow-up from a Single Center

Chenyu Lin, Laura Morrison, Edwin P. Alyea, III, Taewoong Choi, Cristina Gasparetto, Gwynn D. Long, Richard D. Lopez, David A Rizzieri, Stefanie Sarantopoulos, Anthony D. Sung, Nelson J. Chao, Einat Galamidi-Cohen, Aurelie Schwarzbach, Mitchell E. Horwitz
Journal: Blood
Blood (2021) 138 (Supplement 1): 1827.
https://doi.org/10.1182/blood-2021-145535
Published: 2021
Journal Articles

Successful Engraftment of Donor Umbilical Cord Blood (UCB) Cells after Co-Transplantation of Nicord® ( Ex Vivo Expanded UCB Progenitor Cells with Nicotinamide) and a Second Unmanipulated Cord Blood Unit after Myeloablative Chemotherapy in Pediatric Patients with Severe Sickle Cell Disease

Suhag H Parikh, MD, Joel Brochstein, MD, Paul L. Martin, MD PhD, Mitchell E. Horwitz, MD, Einat Galamidi, MD, Iddo Peleg, MSc, MBA, Uri Goshen, M.MDSc., Aurelie Schwarzbach, MSc, David A. Snyder, PhD, Tony Peled, MSc, Joanne Kurtzberg, MD
Journal: Blood
Blood (2016) 128 (22): 3651.
https://doi.org/10.1182/blood.V128.22.3651.3651
Published: 2016